Adiponectin is generally seen as a cardioprotective and anti-inflammatory adipokine, which reduces infarct size in mice (Shibata et al., 2005) and improves cardiac function after experimentally induced myocardial infarction (Shibata et al., 2007). Here, ADIPOQ is linked to myocardial infarction.